News

New initiative targets faster shock diagnosis and care with ‘door to lactate clearance’

New initiative targets faster shock diagnosis and care with ‘door to lactate clearance’

Credit: Pixabay from Pexels A new initiative by The Society for Cardiovascular Angiography & Interventions (SCAI) proposes a new framework and call to action for managing cardiogenic shock (CS), establishing lactate clearance potentially as the standardized, time-based marker of patient trajectory to improve outcomes in one of the deadliest cardiovascular emergencies. “SCAI Door to Lactate

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

Credit: Unsplash/CC0 Public Domain Blood pressure matters at all ages. Children with higher blood pressure at age 7 may be at an increased risk of dying of cardiovascular disease by their mid-50s, according to preliminary research presented at the American Heart Association’s Hypertension Scientific Sessions 2025, held in Baltimore, September 4–7, 2025. The study is

People with sensitive personalities more likely to experience mental health problems, analysis indicates

People with sensitive personalities more likely to experience mental health problems, analysis indicates

Credit: Pixabay/CC0 Public Domain New research, led by Queen Mary University and published in the journal Clinical Psychological Science, has revealed that highly sensitive people (HSP) are more likely to experience mental health problems compared to individuals who are less sensitive. Findings suggest that these individuals could benefit more from interventions such as mindfulness and

Global study finds heart failure drug spironolactone fails to lower cardiovascular risk in dialysis patients

Global study finds heart failure drug spironolactone fails to lower cardiovascular risk in dialysis patients

Credit: Pixabay/CC0 Public Domain A large international study has found that spironolactone, a medication for high blood pressure and heart failure, does not reduce the risk of heart-related death or hospitalizations in people with kidney failure receiving dialysis, despite earlier smaller studies suggesting benefit. The findings are published in The Lancet and were presented at